Deleterious herbal drugs not to classify as prescription drugs.

Published: 2005-10-14 06:58:00

Updated: 2005-10-14 06:58:00

In responding to the inquiry raised by Rep. Kang Ki-jeong of National Assembly about which deleterious herbal drugs such as Ephedra herba and Aconiti tuber should be classified as a prescription drug, the KFDA said it not a right time to review and consider on Oct. 11, since those herbal drugs ha...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK